HFF closes sale of BioMed Realty Trust life sciences facility in Rockville, Maryland

Loading...
Loading...

WASHINGTON, D.C., December 12, 2014 - HFF announced today the sale of 9911 Belward Campus Drive, a 289,912-square-foot large scale biologics manufacturing facility in Rockville, Maryland, that is 100-percent leased through May 2026 to Human Genome Sciences, Inc., a wholly owned subsidiary of GlaxoSmithKline GSK
 
HFF marketed the property on behalf of the owner, BioMed Realty Trust.  The asset was purchased for an undisclosed amount. 

9911 Belward Campus Drive is the single point of production for GSK's FDA-approved lupus treatment Benlysta.  Completed in 2005, the large scale manufacturing site has a fully-integrated warehouse with production and testing capabilities enabling stand-alone production of commercial biologics derived from cell culture.  The facility sits on a 9.55 acre site at the intersection of Interstate 270 and Shady Grove Road in Rockville, which is two miles south of the newly-opened Intercounty Connector and approximately 20 miles northwest of downtown Washington, D.C. 

The HFF investment sales team representing the seller was led by executive managing director Stephen Conley, senior managing directors Jim Meisel, Dek Potts and Andrew Weir, associate director Matt Nicholson and senior real estate analyst Dave Baker.

"This is a very special purpose facility that provides stable cash on cash yields from an investment grade tenant for more than 10 years," Meisel said.

BioMed Realty Trust, Inc. BMR, is a leading provider of real estate solutions to the life science community and offers leasing, development, construction, redevelopment, acquisition, financing and property management services to its tenant partners in the United States and the United Kingdom.  BioMed Realty owns or has interests in properties comprising approximately 17.2 million rentable square feet.  Additional information is available at www.biomedrealty.com.  Follow them on Twitter @BioMedRealty.

HFF (Holliday Fenoglio Fowler, L.P.) and HFFS (HFF Securities L.P.) are owned by HFF, Inc. HF.  HFF operates out of 23 offices nationwide and is a leading provider of commercial real estate and capital markets services to the U.S. commercial real estate industry. HFF together with its affiliate HFFS offer clients a fully integrated national capital markets platform including debt placement, investment sales, equity placement, advisory services, loan sales and commercial loan servicing.  For more information please visit hfflp.com or follow HFF on Twitter @HFF. 

CONTACTS:
JAMES A. MEISEL
HFF Senior Managing Director
(202) 533-2500
jmeisel@hfflp.com

STEPHEN "DEK" POTTS
HFF Senior Managing Director
(202) 533-2500
dpotts@hfflp.com

ANDREW M. WEIR
HFF Senior Managing Director
(202) 533-2500
aweir@hfflp.com

STEPHEN C. CONLEY
HFF Executive Managing Director
(202) 533-2500
sconley@hfflp.com

MATTHEW T. NICHOLSON
HFF Associate Director
(202) 533-2500
mnicholson@hfflp.com

KRISTEN M. MURPHY
HFF Associate Director, Marketing
(617) 338-0990
krmurphy@hfflp.com





This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: HFF, Inc. via Globenewswire

HUG#1879736
Loading...
Loading...
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...